PIM
BPMC

Partner Investment Management’s Blueprint Medicines BPMC Stock Holding History

Partner Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,766
Closed -$782K – 86
2019
Q1 		$782K Sell
9,766
-6,166
-39% -$456K 0.9% 42
2018
Q4 		$859K Buy
15,932
+495
+3% +$30.1K 1.07% 33
2018
Q3 		$1.21M Buy
15,437
+5,648
+58% +$393K 0.92% 42
2018
Q2 		$621K Sell
9,789
-657
-6% -$52.3K 0.5% 72
2018
Q1 		$958K Buy
10,446
+426
+4% +$36.7K 1.04% 43
2017
Q4 		$756K Sell
10,020
-11,232
-53% -$790K 0.87% 44
2017
Q3 		$1.48M Buy
21,252
+2,630
+14% +$141K 1.41% 25
2017
Q2 		$944K Buy
18,622
+2,874
+18% +$122K 1.27% 29
2017
Q1 		$630K Buy
15,748
+5,113
+48% +$183K 0.77% 52
2016
Q4 		$298K Buy
10,635
+1,373
+15% +$41.4K 0.39% 70
2016
Q3 		$275K Sell
9,262
-10,787
-54% -$268K 0.41% 67
2016
Q2 		$406K Buy
20,049
+1,261
+7% +$22.9K 0.66% 50
2016
Q1 		$339K Buy
18,788
+736
+4% +$12.8K 0.55% 50
2015
Q4 		$475K Buy
18,052
+7,898
+78% +$178K 0.78% 43
2015
Q3 		$217K Buy
10,154
+2,804
+38% +$77.6K 0.33% 56
2015
Q2 		$195K Buy
+7,350
New +$210K 0.27% 68

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Partner Investment Management's BPMC Position: Q2 2019 in Review

Partner Investment Management sold out of Blueprint Medicines (BPMC) in Q2 2019, closing a stake of 9,766 shares — an estimated $782K sold.

Partner Investment Management first reported a position in BPMC in Q2 2015 and held it in 16 quarters. The position peaked at $1.48M in Q3 2017. 220 funds tracked by Wall St. Rank hold BPMC as of Q2 2019.

  • Partner Investment Management reported no remaining Blueprint Medicines position as of Q2 2019 after selling out during the quarter.
  • Partner Investment Management sold 9,766 Blueprint Medicines shares in Q2 2019, an estimated $782K.
  • Partner Investment Management first reported a position in Blueprint Medicines in Q2 2015 and held it in 16 quarters.
  • Partner Investment Management's Blueprint Medicines position peaked at $1.48M in Q3 2017.
  • 220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2019.

Based on Partner Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.